Eisai (Misato Factory Operation) Overview

  • Founded
  • 1981
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 210
Employees
  • Latest Deal Type
  • Buyout/​LBO
  • Financing Rounds
  • 1

Eisai (Misato Factory Operation) General Information

Description

Operator of a pharmaceutical plant in Saitama, Japan. The company manufactures pharmaceutical products including tablets and capsules as well as solid dose formulations and parenteral formulations in its facility using the encapsulation processes, enabling the Japanese domestic market and global markets to avail cost-effective pharmaceutical products.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Private Equity-Backed
Primary Industry
Pharmaceuticals
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
  • Saitama Prefecture
  • Saitama
  • Japan
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Eisai (Misato Factory Operation) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Eisai (Misato Factory Operation)‘s full profile, request access.

Request a free trial

Eisai (Misato Factory Operation) Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Eisai (Misato Factory Operation) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Eisai (Misato Factory Operation)‘s full profile, request access.

Request a free trial